Clinical Trial Update: Neoadjuvant Bevacizumab and Carboplatin Followed by Concurrent Bevacizumab, Carboplatin and Radiotherapy in the Primary Treatment of Cervix Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating neoadjuvant bevacizumab and carboplatin followed by concurrent bevacizumab, carboplatin, and radiotherapy for cervical cancer has bee…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• Avastin (bevacizumab)
• CARBOPLATIN (Carboplatin)

Snippet

Sponsor: Leo W. Jenkins Cancer Center | Conditions: Cervical Cancer | Phase 2 | Status: WITHDRAWN